MedPath
FDA Approval

Fosfomycin Tromethamine

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
September 1, 2022
Labeling Type
Human Prescription Drug Label
Fosfomycin(3 g in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Alkem Laboratories Limited

Ascend Laboratories, LLC

677605851

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Fosfomycin Tromethamine

Product Details

NDC Product Code
67877-749
Application Number
ANDA214554
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
September 1, 2022
Code: 7FXW6U30GYClass: ACTIMQuantity: 3 g in 1 1
SUCROSEInactive
Code: C151H8M554Class: IACT
SACCHARINInactive
Code: FST467XS7DClass: IACT
ORANGEInactive
Code: 5EVU04N5QUClass: IACT
© Copyright 2025. All Rights Reserved by MedPath